Alan Patterson, MD
Obstetrics & Gynecology · Coral Springs, FLNPI 1518992346
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,546 of the $5,046 with a category attached, or 70.3%. 22 manufacturers reported payments, led by Scynexis, Inc. at 24.1% of the total. Reporting peaked in 2022 at $1,984 and has fallen 96.5% since, to $69 in 2025.
Across 104 payments — averaging $48.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$1K
- AbbVie$972
- Exeltis, USA Inc.$694
- Organon$475
- Mayne Pharma Commercial LLC$340
- Coopersurgical, Inc.$307
- plus $1K from 16 others
Across 47 payments — averaging $16,481 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sumitomo Pharma America, Inc.$484K
- Mylan Inc.$291K
What the payments were for
- Consulting fees$1,50030%
- Food & beverage$3,54670%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 5 | $1,219 |
| AbbVie(2 entities) | 34 | $972 |
| Exeltis, USA Inc. | 6 | $694 |
| Organon | 3 | $475 |
| Mayne Pharma Commercial LLC | 15 | $340 |
| Coopersurgical, Inc. | 5 | $307 |
| Therapeuticsmd, Inc. | 9 | $220 |
| Amgen | 2 | $122 |
| AMAG Pharmaceuticals, Inc. | 1 | $119 |
| Gen-probe, Inc. | 1 | $100 |
| Lupin Inc. | 4 | $81 |
| Millicent US Inc | 3 | $60 |
| Evofem Biosciences, Inc. | 3 | $58 |
| Hologic Sales And Service, LLC | 2 | $45 |
| Mission Pharmacal Company | 2 | $41 |
| Avion Pharmaceuticals | 3 | $41 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $41 |
| Astellas Pharma US Inc | 1 | $34 |
| Pfizer | 1 | $24 |
| Medicem Inc. | 1 | $22 |
| Myovant Sciences Inc. | 1 | $21 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Slynd$634
- JADA SYSTEM$418
- Orilissa$238
- NEXTSTELLIS$121
- ORIAHNN$120
- INTRAROSA$119
- Summit Doppler$114
- EVENITY$106
How this compares
$5,046 in reported general payments places this provider in the 85th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $654 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Coral Springs
- Joseluis TerrazasCoral Springs$50K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.